MyAverix Finance
F · Healthcare
Galderma Group AG (PY30)
Drug Manufacturers - Specialty & Generic
Galderma Group AG (PY30) is listed on F in the Healthcare sector. Industry: Drug Manufacturers - Specialty & Generic. As of 2026-03-30, reported market cap is $36.36B, P/E ratio is 68.89, net margin is 11.7%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for PY30
Galderma Group AG (PY30) — FAQ
What is Galderma Group AG's market cap?
Galderma Group AG (PY30) has a reported market cap of $36.36B (data as of 2026-03-30).
What is PY30's P/E ratio?
The price-to-earnings (P/E) ratio for Galderma Group AG (PY30) is 68.89 (data as of 2026-03-30).
Does Galderma Group AG pay a dividend?
Dividend yield is not available in the current snapshot for Galderma Group AG (PY30). Check the MyAverix Finance app for the latest dividend data.
What sector is Galderma Group AG in?
Galderma Group AG (PY30) is classified in the Healthcare sector (Drug Manufacturers - Specialty & Generic industry).
What exchange is PY30 listed on?
PY30 is listed on F.
What is Galderma Group AG's net margin?
Galderma Group AG (PY30) reports a net margin of 11.7% (data as of 2026-03-30).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.